In addition to the intrinsically increased number of JAK2 copies, recurrent thrombocytopenia and TPO application might activate the JAK2/STAT3 signaling pathway as a feedback mechanism to stimulate thrombopoiesis. This evidence concerns the gene JAK2 and Thrombocytopenia.